Thus, it is inferable that c-Myb is much likely to act as an upstream regulator of Nrf1 for transcriptionally controlling glucose metabolism, but its dysfunction leads to increased expression of Nrf1 contributable to the pathophysiology of obesity and relevant glucose metabolic dysregulation. The gene discussed is NRF1; the disease is obesity due to melanocortin 4 receptor deficiency.